NCT02022254
- Conditions
- Diabetes, Diabetes Mellitus, Diabetes Mellitus, Type 2, +5 more
- Locations
-
- Novo Nordisk Investigational Site Berlin, Germany
Clinical trial condition
Diabetes Mellitus, Type 2
Explore clinical trials studying Diabetes Mellitus, Type 2. Study availability and eligibility vary by location and protocol.
2,679 public trials
155 recruiting studies
Diabetes Mellitus, Type 2 trial results
NCT00833716
- Conditions
- Diabetes, Diabetes Mellitus, Diabetes Mellitus, Type 2, +12 more
- Locations
-
- Novo Nordisk Investigational Site Miami, Florida, United States
- Novo Nordisk Investigational Site Orlando, Florida, United States
- Novo Nordisk Investigational Site Knoxville, Tennessee, United States
NCT01059799
- Conditions
- Diabetes, Diabetes Mellitus, Diabetes Mellitus, Type 2, +4 more
- Locations
-
- Novo Nordisk Investigational Site Shatin, New Territories, Hong Kong
- Novo Nordisk Investigational Site Chuo-ku, Tokyo, Japan
- Novo Nordisk Investigational Site Kamakura-shi, Kanagawa, Japan
- Novo Nordisk Investigational Site Kawasaki-shi, Japan
Completed
Impact of a Program of Non-pharmacological Intervention in Patients With Type 2 Diabetes Mellitus
NCT02456064
- Conditions
- Diabetes Mellitus, Diabetes Mellitus, Type 2, Endocrine System Diseases, +3 more
- Locations
-
Not specified
NCT00773279
- Conditions
- Autoimmune Diseases, Delivery Systems, Diabetes, +8 more
- Locations
-
- Novo Nordisk Investigational Site Burlingame, California, United States
- Novo Nordisk Investigational Site Concord, California, United States
- Novo Nordisk Investigational Site Encino, California, United States
- Novo Nordisk Investigational Site Escondido, California, United States
NCT01473953
- Conditions
- Diabetes, Diabetes Mellitus, Diabetes Mellitus, Type 2, +5 more
- Locations
-
- Novo Nordisk Investigational Site Evansville, Indiana, United States
Completed
RECORD: Rosiglitazone Evaluated for Cardiac Outcomes and Regulation of Glycaemia in Diabetes
NCT00379769
- Conditions
- Diabetes Mellitus, Diabetes Mellitus, Type 2, Endocrine System Diseases, +3 more
- Locations
-
- GSK Investigational Site Miranda, New South Wales, Australia
- GSK Investigational Site Randwick, New South Wales, Australia
- GSK Investigational Site Wollongong, New South Wales, Australia
- GSK Investigational Site Carina Heights, Queensland, Australia
NCT03088670
- Conditions
- Diabetes Mellitus, Diabetes Mellitus, Type 2, Endocrine System Diseases, +3 more
- Locations
-
- Non-state healthcare Organization "Road Clinical Hospital at the station Chelyabinsk Open Joint Stock Company" Russian Railways Chelyabinsk, Russia
- State Budget Healthcare Institution of Moscow "Endocrinology Dispensary" Moscow, Russia
- SEI HPE "First Moscow State Medical University n.a. I.M. Sechenov of Ministry of Health and Social Development of the Russian Federation", Chair of faculty therapy #2 based at SHI of Moscow "City clinical hospital #61" Moscow, Russia
- State Budget Educational Institution higher professional education "1st Moscow State Medical University n.a. I.M. Sechenov of the Ministry of Healthcare of Russian Federation" Moscow, Russia
Completed
Study In People With Type 2 Diabetes
NCT00196989
- Conditions
- Diabetes Mellitus, Diabetes Mellitus, Type 2, Endocrine System Diseases, +3 more
- Locations
-
- GSK Investigational Site Birmingham, Alabama, United States
- GSK Investigational Site Northport, Alabama, United States
- GSK Investigational Site Chandler, Arizona, United States
- GSK Investigational Site Phoenix, Arizona, United States
- Conditions
- Diabetes, Diabetes Mellitus, Diabetes Mellitus, Type 2, +4 more
- Locations
-
- Novo Nordisk Investigational Site Goodyear, Arizona, United States
- Novo Nordisk Investigational Site Phoenix, Arizona, United States
- Novo Nordisk Investigational Site Anaheim, California, United States
- Novo Nordisk Investigational Site Greenbrae, California, United States